Biora Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-124.12	-38.16	-247.41	-192.8	-228.83	-129.11
Depreciation & Amortization	0.56	0.91	1.44	1.44	4.68	6.07
Share-Based Compensation	16.48	7.8	11.96	8.24	2.38	2.26
Other Operating Activities	58.59	-34.97	66.53	17.1	34.86	55.64
Operating Cash Flow	-48.5	-64.42	-167.49	-165.74	-106.12	-65.13
Capital Expenditures	-0.09	-0.79	-0.86	-3.87	-3.73	-4.83
Change in Investments	0	0	0	0	20.25	60.66
Other Investing Activities	2.54	-	-0.39	-1.07	-	-
Investing Cash Flow	2.44	-0.79	-1.24	-4.94	16.53	55.83
Dividends Paid	0	0	0	0	-4.5	0
Share Issuance / Repurchase	26.14	12.43	172.22	116.44	0.55	-10.81
Debt Issued / Paid	7.74	-5.13	-5.39	92.23	-1.28	-1.75
Other Financing Activities	-3.09	-	-1.78	21.06	78.86	-0.25
Financing Cash Flow	30.78	7.3	165.05	229.72	73.64	-12.81
Net Cash Flow	-15.28	-57.91	-3.68	59.03	-15.96	-22.1
Free Cash Flow	-48.59	-65.21	-168.34	-169.62	-109.85	-69.96
Free Cash Flow Margin	-1214775.00%	-21380.00%	-13499.68%	-104700.62%	-76.29%	-54.67%
Free Cash Flow Per Share	-3.08	-8.54	-43.77	-154.12	-562.44	-375.53

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).